#pharmaceutical industry
4 stories

Germany must turn pharma promises into law
Roche argues Germany's conflicting signals on drug innovation are driving investment and research elsewhere, threatening medical supply and sovereignty.
POLITICO · 2m

Novo CEO eyes M&A deals as weight-loss dominance slips
Novo Nordisk's turnaround plan failed to convince investors, prompting CEO Mike Doustdar to signal openness to acquisitions beyond obesity drugs.
CNBC · 2m

Doceree names 25 healthcare leaders innovating with AI
An awards night celebrates the people using artificial intelligence to transform medicine's future.
Adweek · 1m

Pfizer's federated AI pipeline saves billions
The pharma giant puts machine learning in the hands of scientists, not IT teams, to speed drug discovery and cut costs.
Futuriom · 1m